NEW ORLEANS -- The vast majority of patients with obesity who responded slowly to the once-weekly injectable tirzepatide ...

Treatment guidelines that advise stopping a weight-loss drug if weight loss isn't achieved by 12 weeks don't account for the ...

John Sheppard, MD, MSc, FACs, sat down to discuss post-hoc analysis of 2 FDA registration trials for perfluorohexyloctane, GOBI and MOJAVE, at this year's ARVO meeting held in Seattle, Washington, ...

N EW ORLEANS -- Comparable improvements were observed with teprotumumab (Tepezza) between patients with age-related ...

Today on The McCarthy Report, Andy and Rich discuss the impending impeachment, Trump’s new lawyer, and the pardons enacted by Trump in his final days as president. Today on The McCarthy Report ...

Krishna, Satyapriya, Jiaqi Ma, Dylan Slack, Asma Ghandeharioun, Sameer Singh, and Himabindu Lakkaraju. "Post Hoc Explanations of Language Models Can Improve Language Models." Advances in Neural ...

Although a post-hoc analysis suggested significant reductions in severe bleeding complications for a subset of patients in coronary artery bypass graft surgery, this was not the original primary ...

Salt Lake City Mayor Erin Mendenhall, center, cuts the ribbon at the new Post District residential and commercial development ...

Bhalla, Usha, Suraj Srinivas, and Himabindu Lakkaraju. "Verifiable Feature Attributions: A Bridge between Post Hoc Explainability and Inherent Interpretability." Advances in Neural Information ...

In a post-hoc subgroup analysis, the effect of lixisenatide on MDS-UPDRS part III scores was larger among patients younger than age 60 than those aged 60 and older (MD, 5.22 vs 1.00 points), ...

Q1 2024 Earnings Call Transcript May 7, 2024 Apellis Pharmaceuticals, Inc. reports earnings inline with expectations.